• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

October 18, 2024

Jacque's Post

 

(POWER PRODUCERS WILL BE ONE OF THE BIG INVESTMENTS OF THE FUTURE)

October 18, 2024

 

Hello everyone.

The bullish argument for nuclear power generation.

Vistra (VST) $127.27, Constellation Energy (CEG) $271.20, Talen Energy (TLN)$171.68, Cameco Corp. (CCJ)$56.67

There are strong trends in both energy supply and demand that support the fundamentals of existing nuclear power producers.

Beginning with the supply argument, nuclear power plants are a highly valuable and scarce asset.

Nuclear power plants are valuable because nuclear is the only source of carbon-free energy that is reliable enough to be considered "base load energy." Other sources of reliable energy are either dirty (fossil fuels), are not yet reliable (solar, wind), or are not abundant (hydro, geothermal).

The US has agreed to phase out coal and other dirty power sources over time. Coal used to account for one-third of power generation but now accounts for roughly 10%. This supply gap has largely been filled by natural gas and crude oil (see below chart). Nuclear was previously vilified as a dangerous source of electricity; however, politicians on both sides have become much more pro-nuclear in recent years as an increasingly attractive alternative. This has led to several nuclear plant extensions, talks of restarts, and new tax incentives. 

 

 

 

Nuclear power is scarce because it is extremely costly and timely to build. Almost all US nuclear reactors were built between 1967 and 1990. Regulatory costs skyrocketed after the Three Mile Island accident in 1979. The Vogtle electric plant in Georgia was the only new nuclear plant added in the last 30 years. Vogtle took 15 years and $30 billion to build. Nuclear power plants just aren't economically viable relative to the cost of building new natural gas plants. However, this makes existing plants, like the one Talen owns, more valuable.

Moving on to the demand argument, electricity demand growth is accelerating as the US adopts electric cars and builds more data centers.

Electricity demand has historically grown in line with population growth; however, recent technology shifts have accelerated the demand on the grid. Artificial intelligence applications are more compute-intensive and, therefore, require more electricity. For example, ChatGPT uses as much as 30x more electricity per query than Google search. Research from the Boston Consulting Group projects data center energy use in the US will 3x from 130 terawatt hours in 2022 to 390 terawatt hours by 2030.

JPMorgan analysts are seeing “structural tailwinds, including manufacturing onshoring, broader electrification trends (transportation, heating, and more), as well as data center development underpinning a paradigm shift in power demand.”

Additionally, analysts see that with half of its gas generation in the Texas ERCOT grid, Vistra can also help fill a potential 40-gigawatt supply gap in the Lone Star State by 20230.

 

Vistra (VST) is JPMorgan’s top pick, with a price target of $178. 

 

Vistra Energy (VST) Daily Chart

 

 

Constellation Energy (CEG) is another favourite of JPMorgan in this sector, and the investment bank believes Constellation’s industry-leading nuclear fleet is well-positioned to continue capturing long-term power contracts with data centre developers at premium prices.  Its decision to restart Three Mile Island after signing a power purchase agreement with Microsoft was an industry milestone.

JPMorgan’s price target for Constellation is $342.

 

Constellation Energy (CEG) Daily chart

 

Finally, JPMorgan analysts see Talen’s multidecade agreement with Amazon Web Services to power a data centre campus with electricity generated at the Susquehanna nuclear plant in Pennsylvania could help send the stock higher if it delivers the full 960 megawatts of power to AWS.

Over the next 10 years, AWS has contracted to purchase as much as 1 gigawatt of power per year for a price nearly double the rate of the wholesale power price. Amazon is willing to pay a premium to source reliable carbon-free energy for a large data center, and it will also benefit from certain tax credits associated with the project.

Finally, there may be additional opportunities for per-share value growth above and beyond the AWS deal.  Talen believes there are additional opportunities to co-locate data centers next to its other power plants. Talen's capital allocation strategy of creatively monetizing existing assets while returning capital to shareholders should continue to work.

It is important to remember that there is a wide moat around the business simply because a new nuclear power plant of Susquehanna's scale cannot be replicated at a cost anywhere near the current enterprise value of Talen. 

 

 

JPMorgan’s price target for Talen is $268.

Talen Energy (TLN)

 

Cameco Corp. (CCJ) is a great nuclear power play stock to own for the long term, too.  I have been recommending this stock since early 2024.

 

Cameco Corp. (CCJ) Daily Chart

 

 

I would recommend owning at least two of the power produces illustrated here.  Scaling in is the strategy you should use. 

Earnings Results

Netflix:  Earnings yesterday beat on the top and bottom lines.  Ad-tier memberships jumped 35% quarter over quarter.  Revenue for the full year of 2025 is expected to be between $43 billion and $44 billion.  Advertising is expected to become a primary growth driver from 2026 onwards.

I recommended Netflix on January 17, 2024, when it was $480.00.  I also recommended you either start scaling into the stock or add weight in Jacquie’s Post on October 10.

Goldman Sachs (GS) and JPMorgan (JPM) also reported great earnings.  I also recommended these stocks, or to add weight if you held them, in Jacquie’s Post on October 10.

 

QI CORNER

 

 

SOMETHING TO THINK ABOUT

 

 

 

TRIVIA CORNER

  1. Which country has the longest coastline?
  2. Who was the first U.S. billionaire?
  3. Which first lady was the first to appear on U.S. currency?

Answers in Monday’s Post.

 

 

Cheers

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-18 12:00:402024-10-18 12:27:13October 18, 2024
april@madhedgefundtrader.com

Trade Alert - (DHI) October 18, 2024 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-18 11:20:322024-10-18 11:20:32Trade Alert - (DHI) October 18, 2024 - EXPIRATION AT MAX PROFIT
april@madhedgefundtrader.com

October 18, 2024

Diary, Newsletter, Summary

Global Market Comments
October 18, 2024
Fiat Lux

 

Featured Trade:

(HOW TO FIND A GREAT OPTIONS TRADE)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-18 09:04:072024-10-18 11:11:04October 18, 2024
april@madhedgefundtrader.com

Trade Alert - (NEM) October 18, 2024 - EXPIRATION AT MAX PROFITS

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-17 13:37:132024-10-17 13:42:55Trade Alert - (NEM) October 18, 2024 - EXPIRATION AT MAX PROFITS
april@madhedgefundtrader.com

October 17, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
October 17, 2024
Fiat Lux

 

Featured Trade:

(NO TEARS HERE)

(JNJ)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-17 12:02:372024-10-17 12:07:04October 17, 2024
april@madhedgefundtrader.com

No Tears Here

Biotech Letter

If you've been following my adventures in the market jungle for any length of time, you know I've got a nose for opportunity that'd make a bloodhound jealous. Well, folks, that nose is twitching something fierce, and it's pointed straight at Johnson & Johnson (JNJ).

Now, I know what you're thinking: "John, J&J? Aren't they as exciting as watching paint dry?" Before you dismiss this company, let me tell you—this isn't your grandma's Band-Aid shop anymore.

First off, let's talk about their pharmaceutical arm. It's not just flexing; it's practically bench-pressing the competition with one hand tied behind its back. I'm talking about a lineup that includes immunology juggernauts like Stelara and Tremfya, and cancer-fighting dynamos such as Darzalex and Erleada.

But here's the kicker—they've got over 40 late-stage clinical trials cooking. That's no mere pipeline; it's a veritable gusher of potential blockbusters.

The surprises from J&J don't end there. They recently spun off their consumer health unit faster than you can say "No more tears." Why? To zero in on their real money-makers: pharmaceuticals and medical devices. It's like watching a prizefighter shed weight before a title bout—leaner, meaner, and ready to deliver a knockout punch to the market.

Speaking of punches, J&J has been on an acquisition spree that'd make a Silicon Valley startup blush. On October 9th, they snatched up V-Wave for a cool $1.7 billion, adding to their previous grabs of Abiomed ($16.6 billion in 2022) and Shockwave Medical ($13.1 billion in 2024). And if you think they're splurging just for the heck of it, think again. This triple play gives J&J a solid foothold in the $60 billion cardiovascular device market, which is growing at a heart-racing 8% annually.

So, what does V-Wave bring to a giant like J&J? It's not just another cog in the medical machine. V-Wave is developing innovative treatment options for heart failure patients. Their device has already snagged the FDA's breakthrough device designation in 2019 and Europe's CE mark in 2020. For J&J, this means they can hit the ground running, spreading V-Wave's Ventura Interatrial Shunt across the globe faster than you can say "cardiovascular revolution."

As for their Q3 results? Let's just say J&J didn't settle for merely meeting expectations—they exceeded them. We're looking at a 5.4% adjusted operational revenue growth, with their cardiovascular business shooting up 26.5% year-over-year.

Now, I'm no fortune teller—if I were, I'd be writing this from my private island—but I'd bet my favorite Bloomberg terminal that their cardiovascular business is going to keep pumping life into J&J's MedTech segment. With more folks lining up for cardiovascular procedures than a Black Friday sale, J&J is poised to ride this wave like a pro surfer at Pipeline.

Of course, it's not all sunshine and rainbows. Their China business is facing more headwinds than a kite in a hurricane, thanks to an anti-corruption campaign that's thrown a monkey wrench into their marketing machine.

But hey, this is J&J we're talking about—a company that's been around since Grover Cleveland was in the White House. They've seen tougher times than this and come out swinging.

So, what's the bottom line? I'm slapping a "Buy" rating on this stock, with a fair value of $195 per share. For those of you looking for a stock that combines the stability of a mountain with the growth potential of a tech startup, J&J might just be your golden ticket.

Now, if you'll excuse me, I've got a sudden urge to go check my own blood pressure after all this excitement.

P.S. If J&J ever decides to venture into stem cell therapy for aging knees, you can bet I'll be first in line. These well-worn joints have a few more mountains to climb!

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-17 12:00:332024-10-17 12:06:54No Tears Here
april@madhedgefundtrader.com

October 17, 2024

Diary, Newsletter, Summary

Global Market Comments
October 17, 2024
Fiat Lux

 

Featured Trade:

(FRIDAY OCTOBER 25 SALT LAKE CITY UTAH STRATEGY LUNCHEON)
(THIS IS NOT YOUR FATHER’S NUCLEAR POWER PLANT)
(SMR), (MSFT), (GOOGL), (AMZN)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-17 09:06:372024-10-17 10:23:03October 17, 2024
Mad Hedge Fund Trader

SOLD OUT - Friday, January 31, 2025 Salt Lake City, Utah Strategy Luncheon

Lunch

 

Come join me for the Mad Hedge Fund Trader’s Global Strategy Luncheon, which I will be conducting high in the western desert in Salt Lake City, Utah at the foot of the Rocky Mountains. The event begins at 12:00 noon on Friday, January 31, 2025.

A three-course meal will be provided and an open discussion on the crucial issues facing investors today will take place. The dress is business casual.

I’ll be giving you my up-to-date view on stocks, bonds, foreign currencies, commodities, precious metals, energy, China, and real estate. And to keep you in suspense, I’ll be throwing a few surprises out there too. Tickets are available for $276.

I’ll be arriving early and leaving late in case anyone wants to have a one-on-one discussion, or just sit around and chew the fat about the financial markets.

The event will be held in a private room at a downtown Salt Lake City restaurant, the details of which will be emailed directly to you with your confirmation.

I look forward to meeting you, and thank you for supporting my research.

To purchase tickets for this luncheon, please click here.

 

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2024/10/salt-lake.png 318 564 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-10-17 09:04:362025-02-21 11:48:54SOLD OUT - Friday, January 31, 2025 Salt Lake City, Utah Strategy Luncheon
april@madhedgefundtrader.com

This is Not Your Father’s Nuclear Power Plant.

Diary, Newsletter

A 35% move-up in one day certainly gets one’s attention. The move was prompted by Microsoft’s (MSFT), Google (GOOGL), and Amazon’s (AMZN) move into the nuclear industry to supply electricity for AI data centers over the past two weeks.

Building on my early career at the Atomic Energy Commission in the 1970’s, I have been covering this company since 2012, and it has been a long and windy road. In one shot, they have solved the dozen problems that held the industry back in the 1950’s.

But thanks to Three Mile Island, Chernobyl, and Fukushima, nuclear had the kiss of death on it, making it impossible for the company to raise capital. The Company finally went public in May 2022 at $10.55 with major backing from Bill Gates, with the ticker symbol of (SMR) for “small modular reactor.”

Then, it rallied 60% when it obtained its first order. It then crashed to $1.80 in 2023 when that single order was canceled. It has doubled since September 1, when the new nuclear movement gained traction.

Nuscale’s design eliminates the risk of a meltdown by refining uranium into small pellets and then encasing them with five layers of zirconium. The heat generated is enough to boil water but not go supercritical. The cost of huge billion-dollar containment structures is eliminated by putting the plants underground.

Below, find my original 2012 research piece.

“On my recent trip to Oregon, I met with venture capital investors in NuScale Power, which is trailblazing the brave new world of “new” nuclear. Their technology has been pioneered by Dr. Jose Reyes, dean of the School of Engineering at Oregon State University in Corvallis.

This is definitely not your father’s nuclear power plant. The company has applied for design certification with the Nuclear Regulatory Commission for a mini-light water reactor with a passive cooling system rated at 45 megawatts. The idea is to site a dozen of these together, which in aggregate can generate 540 Megawatts, little more than half the size of the old 1-gigawatt monsters.

Running a dozen small reactors instead of one big one makes for vastly easier operation and maintenance, as individual units can be brought on and offline as needed. Small size also eliminates the need for gargantuan, expensive containment structures.

This power source runs at night when solar and wind plants are offline. Modular design makes mass production of these units economical. Once certification, approval, permitting, and construction are complete, we can expect to see the NuScale plants running by 2018.

After all, if something similar works in nuclear-powered submarines and aircraft carriers, why not in industrial zones on the outskirts of town? For more on NuScale’s innovative efforts, visit their website by clicking here.”

While the stock has already had a great run from the bottom up tenfold, it's probably not too late to buy. This could be another Nvidia-type situation.

 

 

 

 

 

My Old Jeep

https://www.madhedgefundtrader.com/wp-content/uploads/2024/10/old-jeep.png 822 1096 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-17 09:02:102024-10-17 10:22:30This is Not Your Father’s Nuclear Power Plant.
april@madhedgefundtrader.com

October 16, 2024

Tech Letter

Mad Hedge Technology Letter
October 16, 2024
Fiat Lux

 

Featured Trade:

(THE CHIP TRADE IS STILL IN-TACT)
(ASML)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-10-16 14:04:022024-10-16 14:52:22October 16, 2024
Page 221 of 2204«‹219220221222223›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2026. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top